Antiplatelet Therapy in Secondary Prevention of Stroke
Explore this paper's citation graph
Summary
Aspirin is still the most widely accepted first-line treatment for the secondary prevention of stroke, and the combined use of aspirin and dipyridamole has an additive effect in patients with TIA and stroke compared with either drug alone.
- Type
- article
- Published
- 1997-07-01
- Cited by
- 5
- References
- 52
- OpenAlex
- https://openalex.org/W58296422
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:67979173
Keywords
Ticlopidine, Medicine, Aspirin, Dipyridamole, Stroke (engine)
References
- The role of prostacyclin in vascular tissue.
- Adverse effects of aspirin in the treatment of asymptomatic carotid artery stenosis. The VA Cooperative Asymptomatic Carotid Artery Stenosis Study Group.
- Antigenic heterogeneity of vascular endothelium.
- Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine.
- Aspirin dose in stroke prevention: beautiful hypotheses slain by ugly facts.
- The performance of endarterectomy for disease of the extracranial arteries of the head.
- Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls.
- Drugs and surgery in the prevention of ischemic stroke.
- Clopidogrel: An Antithrombotic Drug Acting on the ADP-dependent Activation Pathway of Human Platelets
- Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study.
- Medical Treatment for Stroke Prevention
- Clinical Pharmacokinetics of Ticlopidine
- Ticlopidine
- Controversies in stroke: past and present. The Willis Lecture.
- Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia.
- Pharmacology of Ticlopidine: A Review
- Prothrombotic phenotype diversity of human aortic endothelial cells in culture.
- Danish very-low-dose aspirin after carotid endarterectomy trial.
- Controlled Trial of Aspirin in Cerebral Ischemia
- Aspirin wars: the optimal dose of aspirin prevent stroke.
Cited by
- Medical Management of Acute Coronary Syndromes
- Extended-Release Dipyridamole/Aspirin
- Is the promise of randomized control trials ("evidence-based medicine") overstated?
- Recommendations for stroke management
- Antiagregacijska terapija u sekundarnoj prevenciji moždanog udara Antiplatelet Therapy in Secondary Prevention of Stroke
Related papers
- Antiplatelet therapy for shunt thrombosis
- Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose. Evidence from a meta-analysis.
- [Effect of ticlopidine and dipyridamole on platelet aggregation and count in patients with chronic stable angina pectoris].
- Assessment of antithrombotic agents: effects of dipyridamole analogues on platelet behaviour.
- Thrombotic thrombocytopenic purpura associated with clopidogrel.
- Antithrombotic Activity of DAB-15, a Novel Diazepinobenzimidazole Compound
- Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats.
- Effect of clopidogrel on platelet function in patients with unstable angina pectoris
- Effect of the combination of antiplatelet agents in man: combination of aspirin, trapidil, ticlopidine and dipyridamole.